Cite

HARVARD Citation

    Qi, X. et al. (2022). EGPI-1, a novel eIF4E/eIF4G interaction inhibitor, inhibits lung cancer cell growth and angiogenesis through Ras/MNK/ERK/eIF4E signaling pathway. Chemico-biological interactions. p. . [Online]. 
  
Back to record